MedTrace Logo

Lidocaine Infusion for Propofol Dose Reduction in ERCP Procedure

NCT05274984 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2022-03-11

No results posted yet for this study

Summary

This study aims to investigate the dose reduction of propofol if associated with continuous infusion of lidocaine during ERCP procedures in patients over 65 years old.

Conditions

  • Sedation

Interventions

DRUG

Placebo

the control group will be given the same volume of saline.

DRUG

Lidocaine

the experimental group will be given 1.5mg/kg lidocaine and then 2mg/kg/h

Sponsors & Collaborators

  • Iuliu Hatieganu University of Medicine and Pharmacy

    lead OTHER

Principal Investigators

  • Daniela Ionescu, MD PhD · UMF Iuliu Hatieganu Cluj-Napoca

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-03
Primary Completion
2022-03-03
Completion
2022-04-03

Countries

  • Romania

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05274984 on ClinicalTrials.gov